← Browse by Condition
Medical Condition

anti 3 hydroxy 3 methylglutaryl coa reductase hmgcr immune mediated necrotizing myopathy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06599697 Phase 2
Recruiting

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Enrollment
12 pts
Location
United States
Sponsor
University of Alabama at Birmi...
View Trial →